OSTENIL®

OSTENIL®
Product Description

OSTENIL® is a solution containing hyaluronic acid for injection into the joint cavity.
OSTENIL® is indicated for the treatment of symptoms of osteoarthritis. It has been shown to reduce pain and stiffness in the affected joint and to improve joint function
Pre-filled syringe to relieve pain induced by osteoarthritis. Effective, safe and well-tolerated.
- 1% hyaluronic acid obtained by biofermentation- 3-5 injections at weekly intervals
- For all synovial joints

Read more Show less

TRB Chemedica International SA

  • CH
  • 2016
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    International Approvals/Standards; Quality Service
  • Supplied from
    Switzerland
More specifications Fewer specifications

TRB Chemedica International SA

  • CH
  • 2016
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
View company profile

More Products from TRB Chemedica International SA (10)

  • OSTENIL® mini

    Product OSTENIL® mini

    OSTENIL® mini is indicated for the treatment of symptoms of osteoarthritis in small synovial joints such as the carpometacarpal joint of the hand, the ankle joint, the temporomandibular joint and the facet joint of the spine. OSTENIL® MINI: pre-filled syringe to relieve pain induced by osteoarthritis....
  • OSTENIL® Plus

    Product OSTENIL® Plus

    OSTENIL® PLUS is a unique combination of natural high dose HA (2%) + mannitol.
    The formulation offers the possibility of reducing the number of intra-articular injections and increasing the intervals between injections.  OSTENIL® PLUS: pre-filled syringe to relieve pain induced by ...
  • OSTENIL® Tendon

    Product OSTENIL® Tendon

    OSTENIL® TENDON was developed to treat pain and restricted mobility in tendon disorders. It is a conservative treatment based on the biomechanical properties of hyaluronic acid.
    OSTENIL® TENDON is injected into the tendon sheath (intrasheath injection) or around the affected tendon (peritendinous i...
  • REMOGEN® Omega

    Product REMOGEN® Omega

    REMOGEN® OMEGA is indicated in case of ocular surface damage such as irritation, redness, burning, pain, dry eye, ocular fatigue and foreign body sensation.

    REMOGEN® OMEGA is an innovative patented preservative-free eye drop formulation of topical Omega-3 polyunsaturated fatty acids...
  • VISCOSEAL® syringe

    Product VISCOSEAL® syringe

    VISCOSEAL® is a viscoelastic solution containing hyaluronic acid. This solution has viscoelastic properties that are very close to those of normal synovial fluid.

    VISCOSEAL® is indicated as a synovial fluid replacement after arthroscopy. In clinical trials, it has been shown to relieve p...
  • VISMED®

    Product VISMED®

    VISMED® is a unique preservative-free lubricant eye drop that offers an unmatched combination of long-lasting relief of sensations of ocular dryness with optimal eye comfort.

    VISMED® is compatible with all types of contact lenses (rigid or soft) during wear.

    VISMED® is...
  • VISMED® Gel

    Product VISMED® Gel

    VISMED® GEL  is a preservative-free viscoelastic solution for sustained lubrication of the eyes in case of sensations of dryness, burning or ocular fatigue induced by environmental conditions, extended computer screen use, contact lens wear or by ophthalmological screening methods.
    VISMED® GE...
  • VISMED® Gel Multi

    Product VISMED® Gel Multi

    VISMED®  GEL is a patented hypotonic formulation that contains both 0.30% sodium hyaluronate, a natural polymer which is also present in the structures of human eyes, and most of the essential ions that are present in natural tears.

    VISMED®  GEL MULTI is indicated in case of sy...
  • VISMED® Light

    Product VISMED® Light

    VISMED® LIGHT is a multidose contact lens lubricant that offers a cost-effective alternative for long-term relief of mild ocular discomfort during hard or soft contact lens wear.

    VISMED® LIGHT is a 0.1% solution of sodium hyaluronate, a natural polymer which is also present in the struct...
  • VISMED® Multi

    Product VISMED® Multi

    VISMED® MULTI is a unique lubricant eye drop in an innovative preservative-free, multidose system. VISMED® multi offers an unmatched combination of long-lasting relief of sensations of ocular dryness and optimal eye comfort.

    VISMED® MULTI is a patented hypotonic formulation that contains both 0...

TRB Chemedica International SA resources (8)

  • COVID-19, how we adapt and respond to the situation

    News COVID-19, how we adapt and respond to the situation

    The current COVID-19 pandemy impacts daily lives globally. As the crisis continues to evolve, it also shifts our ways of working and thinking. We at TRB are working hard to maintain our products and services and continue to make them available as we do during “normal times”.
    15 Apr 2021
  • TRB SWISS MANUFACTURING PLANT

    Brochure TRB SWISS MANUFACTURING PLANT

    Presentation of TRB Swiss plant based in Vouvry.
  • OPHTHALMOLOGY

    News OPHTHALMOLOGY

    We have developed the VISMED® range of lubricant eye drops consisting in hypo-osmolar sodium hyaluronate solutions indicated for the treatment of symptoms and signs of dry eye
    15 Apr 2021
  • Vismed Range hyaluronic acid for all your needs

    Brochure Vismed Range hyaluronic acid for all your needs

    Presentation of the Vismed range for dry eye from TRB Chemedica
  • RHEUMATOLOGY

    News RHEUMATOLOGY

    TRB Chemedica researches, develops, manufactures and markets different molecules to treat osteoarthritis-induced pain such as hyaluronic acid-based products and diacerein. OSTENIL® range consists of sodium hyaluronate-containing products with different formulations and has been developed to improve osteoarthritis patients’ symptoms and joint function after intra-articular injection.
    15 Apr 2021
  • Diacerein, Oral inhibition of interleukin-1 in the treatment of osteoarthritis

    Brochure Diacerein, Oral inhibition of interleukin-1 in the treatment of osteoarthritis

    DIACEREIN is indicated for the specific, long-term oral treatment of degenerative joint diseases (osteoarthritis and related diseases). DIACEREIN has a unique mode of action through inhibition of the production and activity of interleukin-1, the key mediator in the progression of osteoarthritis.
  • HYALURONIC ACID

    News HYALURONIC ACID

    TRB Chemedica has pioneered the use of sodium hyaluronate obtained by biofermentation, with a focus on patient safety and improved clinical outcomes.Due to its high biocompatibility and common presence in the extracellular matrix of tissues, hyaluronic acid has gained popularity during recent decades and is now used in many fields of medicine, such as orthopaedics, rheumatology, ophthalmology, tissue repair...
    15 Apr 2021
  • Our new Swiss website is now live, find out more about TRB products for Switzerland

    News Our new Swiss website is now live, find out more about TRB products for Switzerland

    We are thrilled to announce the launch of our new Swiss website available in four different languages (German, French, Italian and English).

    15 Apr 2021